Member Info for TrickyEFC

Some god old tnt may clear the board here 😉

⛽ Full of gas

0.8p

Who said sub 0.7 😆

Someone's still buying rather large

04-Feb-25 15:54:30 0.8932 3,113,860 Unknown* 27.81k

A buy for around 15million shares would be a good end to another good day

Would be nice to see Sam.

As for news yep would assume it can't be too far Orr.

0.2s to sell now

0.198 to sell

Mms want more now.

Will take over 10 million now at 0.1922

Not sure they had today's date on.

That last trade printed black at 0.2p.

Surely a buy but if they bidding 0.2p that's even better

That it has. seems to be somewhat under the radar and hopefully that most of the recent buyers are in it for the medium to long term.

The ain't much to grumble about here.

Welcome aboard madenglish.

Bid for up to 3 mill is 0.1961

Would love to see a few more big buys orders over coming days to go with the decent level of live buys.

Hi daffy it's only Wednesday give it till march 😉😆

They offering a fair bit over bid for up to 7mill.

Hopefully a lil flurry of buyers this avo will get us to 0.23s

Should maybe stop but can't stop buying 🤪

Another half million 🤪😁

And progressing nicely

Awakn 2

Awakn Announces Positive Outcome of Pre-IND Meeting with FDA for AWKN-002 in Alcohol Use Disorder

https://awaknlifesciences.com/awkn-002-pre-ind-fda

If we get to this stage then it's a big knock knock and awakn will sell it off to the highest bidder.

If the last post don't get ya all pumped up don't know what will, the last bit 👀👀 discussions with the people who have funded this venture UK DH

Awakn is planning to commence market access discussions with the UK Department of Health this year.

The phase 2 results also demonstrated an on average 86% abstinence rate in the 6 months post treatment versus 2% abstinence pre-trial.

Regulatory path and exclusivity: Awakn is targeting a Regulation 52b hybrid application in the UK for AWKN-001. If successful, this could provide 8 years of market exclusivity, with an additional 2 years of supplementary protection, preventing competitors from marketing a similar product for the same indication. Awakn is planning to commence market access discussions with the UK Department of Health this year.

Think my maths was off.

1billion be bout 40p

And 10b £4

Ps rounded off